Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model. (Q37861522)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 August 2006

Language	Label	Description	Also known as
English	Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model.	scientific article published on 11 August 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Chlamydia pneumoniae infection

1 reference

based on heuristic

inferred from title

Chlamydia pneumoniae

object named as

Chlamydia pneumoniae

1 reference

based on heuristic

inferred from title

Mirja Puolakkainen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Tammiruusu A

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Penttilä T

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lahesmaa R

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sarvas M

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Vuola JM

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

0 references

publication date

11 August 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

283-290

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Proteins in the chlamydial inclusion membrane

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

An Inclusion Membrane Protein from Chlamydia trachomatis Enters the MHC Class I Pathway and Stimulates a CD8+ T Cell Response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Experimental infection by Chlamydia pneumoniae in the hamster

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Chlamydia pneumoniae and severity of asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Chlamydial infections of the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.07.043

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16949182%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37861522&oldid=2159276533"